ID   UBP48_HUMAN             Reviewed;        1035 AA.
AC   Q86UV5; B7ZKS7; Q2M3I4; Q5SZI4; Q5T3T5; Q6NX53; Q8N3F6; Q96F64;
AC   Q96IQ3; Q9H5N3; Q9H5T7; Q9NUJ6; Q9NXR0;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   12-APR-2017, entry version 138.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 48;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 48;
DE   AltName: Full=Ubiquitin thioesterase 48;
DE   AltName: Full=Ubiquitin-specific-processing protease 48;
GN   Name=USP48; Synonyms=USP31;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=15354349; DOI=10.1080/10855660310001638197;
RA   Lockhart P.J., Hulihan M., Lincoln S., Hussey J., Skipper L.,
RA   Bisceglio G., Wilkes K., Farrer M.J.;
RT   "Identification of the human ubiquitin specific protease 31 (USP31)
RT   gene: structure, sequence and expression analysis.";
RL   DNA Seq. 15:9-14(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 712-1035 (ISOFORM 1).
RC   TISSUE=Colon, Hepatoma, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 8), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 399-1035 (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-636 (ISOFORMS 1/2).
RC   TISSUE=Colon, Eye, Pancreas, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 691-1035 (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C.,
RA   Cal S., Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   ALTERNATIVE SPLICING (ISOFORM 7), ENZYME ACTIVITY, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH RELA
RP   AND TRAF2.
RX   PubMed=16214042; DOI=10.1016/j.cellsig.2005.03.017;
RA   Tzimas C., Michailidou G., Arsenakis M., Kieff E., Mosialos G.,
RA   Hatzivassiliou E.G.;
RT   "Human ubiquitin specific protease 31 is a deubiquitinating enzyme
RT   implicated in activation of nuclear factor-kappaB.";
RL   Cell. Signal. 18:83-92(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-956, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-886; SER-887 AND
RP   SER-888, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-886 AND SER-888, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Recognizes and hydrolyzes the peptide bond at the C-
CC       terminal Gly of ubiquitin. Involved in the processing of poly-
CC       ubiquitin precursors as well as that of ubiquitinated proteins.
CC       May be involved in the regulation of NF-kappa-B activation by TNF
CC       receptor superfamily via its interactions with RELA and TRAF2. May
CC       also play a regulatory role at postsynaptic sites.
CC       {ECO:0000269|PubMed:16214042}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:16214042}.
CC   -!- SUBUNIT: Interacts with TRAF2 and RELA.
CC       {ECO:0000269|PubMed:16214042}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16214042}.
CC       Nucleus {ECO:0000269|PubMed:16214042}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=Q86UV5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UV5-2; Sequence=VSP_020480;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q86UV5-3; Sequence=VSP_020479;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q86UV5-4; Sequence=VSP_020473, VSP_020474;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q86UV5-5; Sequence=VSP_020472, VSP_020475, VSP_020478,
CC                                  VSP_020480;
CC         Note=Ref.3 (BAB15533) sequence differs from that shown due to a
CC         frameshift in position 109. No experimental confirmation
CC         available. {ECO:0000305};
CC       Name=6;
CC         IsoId=Q86UV5-6; Sequence=VSP_020471, VSP_020481;
CC         Note=No experimental confirmation available.;
CC       Name=7; Synonyms=USP31S1;
CC         IsoId=Q86UV5-7; Sequence=VSP_020476, VSP_020477;
CC       Name=8;
CC         IsoId=Q86UV5-8; Sequence=VSP_054487, VSP_054488;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:14715245, ECO:0000269|PubMed:15354349,
CC       ECO:0000269|PubMed:16214042}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- CAUTION: Was termed (PubMed:15354349 and PubMed:17081983) USP31.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13567.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH67261.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAI03725.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA92128.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI12124.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI16260.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF502942; AAP30832.1; -; mRNA.
DR   EMBL; AL590103; CAI12124.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL590103; CAI12127.1; -; Genomic_DNA.
DR   EMBL; AL359815; CAI12127.1; JOINED; Genomic_DNA.
DR   EMBL; AL359815; CAI16256.1; -; Genomic_DNA.
DR   EMBL; AL590103; CAI16256.1; JOINED; Genomic_DNA.
DR   EMBL; AL359815; CAI16260.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK000110; BAA90950.1; -; mRNA.
DR   EMBL; AK002190; BAA92128.1; ALT_INIT; mRNA.
DR   EMBL; AK026707; BAB15533.1; ALT_FRAME; mRNA.
DR   EMBL; AK026930; BAB15591.1; -; mRNA.
DR   EMBL; BC007326; AAH07326.2; -; mRNA.
DR   EMBL; BC013567; AAH13567.1; ALT_INIT; mRNA.
DR   EMBL; BC067261; AAH67261.1; ALT_SEQ; mRNA.
DR   EMBL; BC103724; AAI03725.1; ALT_SEQ; mRNA.
DR   EMBL; BC104896; AAI04897.1; -; mRNA.
DR   EMBL; BC143354; AAI43355.1; -; mRNA.
DR   EMBL; AL834375; CAD39038.1; -; mRNA.
DR   CCDS; CCDS30623.1; -. [Q86UV5-1]
DR   CCDS; CCDS44084.1; -. [Q86UV5-7]
DR   CCDS; CCDS81277.1; -. [Q86UV5-2]
DR   RefSeq; NP_001027902.1; NM_001032730.1. [Q86UV5-7]
DR   RefSeq; NP_001317323.1; NM_001330394.1. [Q86UV5-2]
DR   RefSeq; NP_115612.4; NM_032236.6. [Q86UV5-1]
DR   UniGene; Hs.467524; -.
DR   ProteinModelPortal; Q86UV5; -.
DR   SMR; Q86UV5; -.
DR   BioGrid; 123941; 33.
DR   IntAct; Q86UV5; 3.
DR   MINT; MINT-7944238; -.
DR   STRING; 9606.ENSP00000309262; -.
DR   MEROPS; C19.068; -.
DR   iPTMnet; Q86UV5; -.
DR   PhosphoSitePlus; Q86UV5; -.
DR   BioMuta; USP48; -.
DR   DMDM; 74750436; -.
DR   EPD; Q86UV5; -.
DR   MaxQB; Q86UV5; -.
DR   PaxDb; Q86UV5; -.
DR   PeptideAtlas; Q86UV5; -.
DR   PRIDE; Q86UV5; -.
DR   Ensembl; ENST00000308271; ENSP00000309262; ENSG00000090686. [Q86UV5-1]
DR   Ensembl; ENST00000400301; ENSP00000383157; ENSG00000090686. [Q86UV5-2]
DR   Ensembl; ENST00000421625; ENSP00000406256; ENSG00000090686. [Q86UV5-7]
DR   Ensembl; ENST00000529637; ENSP00000431949; ENSG00000090686. [Q86UV5-8]
DR   GeneID; 84196; -.
DR   KEGG; hsa:84196; -.
DR   UCSC; uc001bfb.4; human. [Q86UV5-1]
DR   CTD; 84196; -.
DR   DisGeNET; 84196; -.
DR   GeneCards; USP48; -.
DR   HGNC; HGNC:18533; USP48.
DR   HPA; HPA030045; -.
DR   HPA; HPA030046; -.
DR   neXtProt; NX_Q86UV5; -.
DR   OpenTargets; ENSG00000090686; -.
DR   PharmGKB; PA134947522; -.
DR   eggNOG; KOG1863; Eukaryota.
DR   eggNOG; COG5077; LUCA.
DR   GeneTree; ENSGT00760000119158; -.
DR   HOGENOM; HOG000231639; -.
DR   HOVERGEN; HBG080368; -.
DR   InParanoid; Q86UV5; -.
DR   KO; K11858; -.
DR   OMA; MGDGIQE; -.
DR   OrthoDB; EOG091G00SZ; -.
DR   PhylomeDB; Q86UV5; -.
DR   TreeFam; TF106280; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP48; human.
DR   GeneWiki; USP48; -.
DR   GenomeRNAi; 84196; -.
DR   PRO; PR:Q86UV5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000090686; -.
DR   CleanEx; HS_USP31; -.
DR   CleanEx; HS_USP48; -.
DR   ExpressionAtlas; Q86UV5; baseline and differential.
DR   Genevisible; Q86UV5; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IEA:InterPro.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   CDD; cd02668; Peptidase_C19L; 1.
DR   Gene3D; 3.30.2230.10; -; 3.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   InterPro; IPR033841; USP48.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   SUPFAM; SSF143791; SSF143791; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS51283; DUSP; 3.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Hydrolase; Nucleus; Phosphoprotein; Polymorphism; Protease;
KW   Reference proteome; Repeat; Thiol protease; Ubl conjugation pathway.
FT   CHAIN         1   1035       Ubiquitin carboxyl-terminal hydrolase 48.
FT                                /FTId=PRO_0000249523.
FT   DOMAIN       89    421       USP.
FT   DOMAIN      460    554       DUSP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      569    691       DUSP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      711    824       DUSP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      929   1009       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   ACT_SITE     98     98       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   ACT_SITE    353    353       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     886    886       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     887    887       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     888    888       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     956    956       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1    875       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020471.
FT   VAR_SEQ       1    469       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020472.
FT   VAR_SEQ     369    392       FNDEDIEKMEGKKLQLGIEEDLAE -> LILNTNYHLPPSP
FT                                KPIKIKNYNKP (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020473.
FT   VAR_SEQ     391    391       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054487.
FT   VAR_SEQ     393   1035       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020474.
FT   VAR_SEQ     470    483       EEVKELYQRLPAGA -> MNLSLSQKTVKIHRLFPMLAFS
FT                                (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020475.
FT   VAR_SEQ     484    485       EP -> GL (in isoform 7). {ECO:0000305}.
FT                                /FTId=VSP_020476.
FT   VAR_SEQ     486   1035       Missing (in isoform 7). {ECO:0000305}.
FT                                /FTId=VSP_020477.
FT   VAR_SEQ     589    589       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020478.
FT   VAR_SEQ     654    654       H -> HAVFFFSKYIFLNS (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054488.
FT   VAR_SEQ     704   1035       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020479.
FT   VAR_SEQ     909    960       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020480.
FT   VAR_SEQ    1020   1035       VCMPEEGFKGTGLLGH -> GKDEFVLGIC (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020481.
FT   VARIANT     125    125       S -> C (in dbSNP:rs4253886).
FT                                /FTId=VAR_027427.
FT   VARIANT     135    135       E -> K (in dbSNP:rs12097805).
FT                                /FTId=VAR_027428.
SQ   SEQUENCE   1035 AA;  119032 MW;  6F7DAF88527E2627 CRC64;
     MAPRLQLEKA AWRWAETVRP EEVSQEHIET AYRIWLEPCI RGVCRRNCKG NPNCLVGIGE
     HIWLGEIDEN SFHNIDDPNC ERRKKNSFVG LTNLGATCYV NTFLQVWFLN LELRQALYLC
     PSTCSDYMLG DGIQEEKDYE PQTICEHLQY LFALLQNSNR RYIDPSGFVK ALGLDTGQQQ
     DAQEFSKLFM SLLEDTLSKQ KNPDVRNIVQ QQFCGEYAYV TVCNQCGRES KLLSKFYELE
     LNIQGHKQLT DCISEFLKEE KLEGDNRYFC ENCQSKQNAT RKIRLLSLPC TLNLQLMRFV
     FDRQTGHKKK LNTYIGFSEI LDMEPYVEHK GGSYVYELSA VLIHRGVSAY SGHYIAHVKD
     PQSGEWYKFN DEDIEKMEGK KLQLGIEEDL AEPSKSQTRK PKCGKGTHCS RNAYMLVYRL
     QTQEKPNTTV QVPAFLQELV DRDNSKFEEW CIEMAEMRKQ SVDKGKAKHE EVKELYQRLP
     AGAEPYEFVS LEWLQKWLDE STPTKPIDNH ACLCSHDKLH PDKISIMKRI SEYAADIFYS
     RYGGGPRLTV KALCKECVVE RCRILRLKNQ LNEDYKTVNN LLKAAVKGSD GFWVGKSSLR
     SWRQLALEQL DEQDGDAEQS NGKMNGSTLN KDESKEERKE EEELNFNEDI LCPHGELCIS
     ENERRLVSKE AWSKLQQYFP KAPEFPSYKE CCSQCKILER EGEENEALHK MIANEQKTSL
     PNLFQDKNRP CLSNWPEDTD VLYIVSQFFV EEWRKFVRKP TRCSPVSSVG NSALLCPHGG
     LMFTFASMTK EDSKLIALIW PSEWQMIQKL FVVDHVIKIT RIEVGDVNPS ETQYISEPKL
     CPECREGLLC QQQRDLREYT QATIYVHKVV DNKKVMKDSA PELNVSSSET EEDKEEAKPD
     GEKDPDFNQS NGGTKRQKIS HQNYIAYQKQ VIRRSMRHRK VRGEKALLVS ANQTLKELKI
     QIMHAFSVAP FDQNLSIDGK ILSDDCATLG TLGVIPESVI LLKADEPIAD YAAMDDVMQV
     CMPEEGFKGT GLLGH
//
